Bovie Medical Corporation (BVX) is a leading maker of medical devices and supplies as well as the developer of J- Plasma, a patented plasma-based surgical product for cutting and coagulation.
J-Plasma utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.
We recommended Bovie Medical twice, and the stock has been a profitable investment. Our last buy was in the May 2016 issue at $1.87.
The stock more than tripled to a high of $5.75 or +207% in about five months. Now that the price has fallen back, we’re taking another look at the company.
We like Bovie Medical for the longer term, primarily because of its J-Plasma product, which we think has great potential. If the company releases positive news on its J-Plasma product and returns to profitability, the stock could easily double over the next couple of years.
